Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Cure Pharmaceutical Holding Corp. | curr_ex321.htm |
| EX-31.2 - CERTIFICATION - Cure Pharmaceutical Holding Corp. | curr_ex312.htm |
| EX-31.1 - CERTIFICATION - Cure Pharmaceutical Holding Corp. | curr_ex311.htm |
| 10-Q - FORM 10-Q - Cure Pharmaceutical Holding Corp. | curr_10q.htm |
EXHIBIT 32.2
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S. C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CURE Pharmaceutical Holding Corp., (the “Company”) on Form 10-Q for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Redard, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
|
| (1) | The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and |
|
| ||
|
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. |
| Date: November 13, 2020 | By: | /s/ Michael Redard | |
|
| Michael Redard | ||
|
| Chief Financial Officer |